Search by Drug Name or NDC

NDC 60977-0145-01 DAPZURA RT 500 mg/10mL Details

DAPZURA RT 500 mg/10mL

DAPZURA RT is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is DAPTOMYCIN.

MedlinePlus Drug Summary

Daptomycin injection is used to treat certain blood infections or serious skin infections caused by bacteria in adults and children 1 year of age and older. Daptomycin injection is in a class of medications called cyclic lipopeptide antibiotics. It works by killing bacteria. Antibiotics such as daptomycin injection will not work for treating colds, flu, or other viral infections. Using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.

Related Packages: 60977-0145-01
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Daptomycin Injection

Product Information

NDC	60977-0145
Product ID	60977-145_3611913b-b54f-4f60-a738-4f650400ccff
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	DAPZURA RT
Proprietary Name Suffix	n/a
Non-Proprietary Name	daptomycin
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route	INTRAVENOUS
Active Ingredient Strength	500
Active Ingredient Units	mg/10mL
Substance Name	DAPTOMYCIN
Labeler Name	Baxter Healthcare Corporation
Pharmaceutical Class	Lipopeptide Antibacterial [EPC], Lipopeptides [CS]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA213645
Listing Certified Through	2024-12-31

Package

NDC 60977-0145-01 (60977014501)

Pricing Information	N/A
NDC Package Code	60977-145-01
Billing NDC	60977014501
Package	1 VIAL in 1 CARTON (60977-145-01) / 10 mL in 1 VIAL
Marketing Start Date	2022-01-25
NDC Exclude Flag	N